Pacegenix, Inc. — Form D
Pacegenix, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-26. The offering totals $22.5M, of which $22.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-03-26
- Form: D
- Accession: 0002117706-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $22.5M
- Amount sold: $22.5M
- Investors: 15
- Date of first sale: 2026-03-11
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-577711
Issuer
- Name: Pacegenix, Inc.
- CIK: 0002117706
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 245 1ST ST, 18TH FLOOR, CAMBRIDGE, MA, 02142
- Phone: 6126850244
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Fredric Neville Eshelman | Director | Cambridge, MA |
| Raymond Glenn Tabibiazar | Director | Cambridge, MA |
| Jay Glenn Wohlgemuth | Director | Cambridge, MA |
| Frank Neville Grazzini, II | Executive Officer | Cambridge, MA |
| Jay Glenn Wohlgemuth | Executive Officer | Cambridge, MA |
More